PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 44 trials

Enrolling now

Nationwide

64Cu-GRIP B in Patients With Advanced Malignancies

Rahul Aggarwal

Procedure·Ph 1/2·~4yr·1 site in CA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Clinical Trial of KTX-2001 for Prostate Cancer

K36 Therapeutics, Inc.

Ph 1·~3yr·13 sites in CA, FL, MN +6

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

AstraZeneca

Ph 1·~4yr·11 sites in CA, FL, IL +7

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of FG-3246 for Prostate Cancer

Kyntra Bio

Ph 2·~2yr·15 sites in AZ, CA, FL +8

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Daiichi Sankyo

Ph 1·~4yr·3 sites in SC, TX, VA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Amgen

Ph 3·~7yr·23 sites in AZ, CA, CO +13

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer

AbbVie

Ph 1·~3yr·9 sites in CA, CT, FL +5

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Hoffmann-La Roche

Ph 2·~3yr·4 sites in CA, IA, NY +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Trial to Find Out if REGN4336 is Safe and How Well it Works for Prostate Cancer

Regeneron Pharmaceuticals

Ph 1/2·~5yr·13 sites in CA, CT, KY +8

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Blue Earth Therapeutics Ltd

Ph 1/2·~6yr·5 sites in FL, GA, NE +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

H. Lee Moffitt Cancer Center and Research Institute

Ph 1·~9yr·1 site in FL

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC

H. Lee Moffitt Cancer Center and Research Institute

Ph 2·1 site in FL

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

XALute Trial

Amgen

Ph 3·~5yr·42 sites in AL, CA, FL +20

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

Brigham and Women's Hospital

Ph 4·~1.5yr·2 sites in MA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Ph 2·~8yr·1 site in MD

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

COSMYC Trial

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Ph 2·~6yr·1 site in MD

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617

Ebrahim S Delpassand

Ph 2·~4yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

Zenith Epigenetics

Ph 2·~5yr·16 sites in CA, CO, FL +10

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of DS9051b

Daiichi Sankyo

Ph 1·~2yr·3 sites in FL, NY, RI

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Bristol-Myers Squibb

Ph 1·8 sites in CA, FL, MA +4

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Compare BMS-986365 Versus Investigator's Choice Therapy for Advanced Prostate Cancer

Celgene

Ph 3·~4yr·53 sites in AL, AZ, CA +22

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

Yale University

Ph 2·~4yr·1 site in CT

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Lu-177 Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application

FutureChem

Ph 1/2·~3yr·4 sites in CA, MD, PA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Safety and Dose-finding Trial of PRL-02 Depot in Men With Advanced Prostate Cancer

Astellas Pharma Global Development, Inc.

Ph 1·~8yr·24 sites in AZ, CA, FL +14

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify